Skip to main content
. 2018 May 18;7(11):e008123. doi: 10.1161/JAHA.117.008123

Figure 2.

Figure 2

Overall survival among patients with STEMI, according to quartiles of admission MR‐proADM. The MR‐proADM levels were as follows: first quartile ≤0.52 nmol/L, second quartile 0.53 to 0.64 nmol/L, third quartile 0.65 to 0.78 nmol/L and fourth quartile ≥0.79 nmol/L. MR‐proADM indicates midregional proadrenomedullin; STEMI, ST‐segment–elevation myocardial infarction.